Search Results

Irbesartan Inhibits Albumin-Elicited Proximal Tubular Cell Apoptosis and Injury In Vitro

Authors: Matsui, Takanori; Yamagishi, Sho-ichi; Ueda, Seiji; Fukami, Kei; Okuda, Seiya

Source: Protein and Peptide Letters, Volume 17, Number 1, January 2010 , pp. 74-77(4)

Publisher: Bentham Science Publishers

Irbesartan has no short-term effect on insulin resistance in hypertensive patients with additional cardiometabolic risk factors (i-RESPOND)

Authors: Parhofer, K. G.; Birkeland, K. I.; DeFronzo, R.; Del Prato, S.; Bhaumik, A.; Ptaszynska, A.

Source: International Journal of Clinical Practice, Volume 64, Number 2, January 2010 , pp. 160-168(9)

Publisher: Blackwell Publishing

Irbesartan-mediated reduction of renal and cardiac damage in insulin resistant JCR : LA-cp rats

Authors: Russell, JC; Kelly, SE; Vine, DF; Proctor, SD

Source: British Journal of Pharmacology, Volume 158, Number 6, November 2009 , pp. 1588-1596(9)

Publisher: Blackwell Publishing

Matrix Elimination Ion Chromatography Method for Trace Level Azide Determination in Irbesartan Drug

Authors: Subramanian, Narayanan Harihara; Babu, V.R. Sankar; Jeevan, R. Ganesh; Radhakrishnan, Ganga

Source: Journal of Chromatographic Science, Volume 47, Number 7, August 2009 , pp. 529-533(5)

Publisher: Preston Publications

Amlodipine/Valsartan Single-Pill Combination: A Review of its Use in the Management of Hypertension

Authors: Frampton, James E.; Scott, Lesley J.

Source: American Journal of Cardiovascular Drugs, Volume 9, Number 5, 1 October 2009 , pp. 309-330(22)

Publisher: Adis International

Irbesartan/hydrochlorothiazide/lansoprazole: Severe hyponatraemia (first report for irbesartan) in an elderly patient: case report

Source: Reactions, Volume 1, Number 1273, 2009-10-10 , pp. 19-20(2)

Publisher: Adis International

Drugs with Blocking Effects on the Renin-Angiotensin-Aldosterone System Do Not Improve Endothelial Dysfunction Long-term in Hypertensive Patients

Authors: Sozen, A.B.; Kayacan, M.S.; Tansel, T.; Celebi, A.; Kudat, H.; Akkaya, V.; Erk, O.; Hatipoglu, I.; Demirel, S.

Source: The Journal of International Medical Research, Volume 37, Number 4, July 2009 , pp. 996-1002(7)

Publisher: Field House Publishing

Irbesartan/losartan: Multiple toxicities in pregnant women and their neonates following in utero exposure: 7 case reports

Source: Reactions, Volume 1, Number 1259, 2009-07-04 , pp. 20-20(1)

Publisher: Adis International

Combination of clopidogrel and aspirin for reduction of vascular events in patients with atrial fibrillation

Authors: Kantharia, Bharat K; Shah, Arti N

Source: Expert Review of Cardiovascular Therapy, Volume 7, Number 7, July 2009 , pp. 749-753(5)

Publisher: Expert Reviews

Understanding Heart Failure With Preserved Ejection Fraction: Clinical Importance and Future Outlook

Authors: Miller, Alan B.; Piña, Ileana L.

Source: Congestive Heart Failure, Volume 15, Number 4, July/August 2009 , pp. 186-192(7)

Publisher: Blackwell Publishing

The Effects of Antihypertensive Treatment on the Doppler-Derived Myocardial Performance Index in Patients with Hypertensive Left Ventricular Hypertrophy: Results from the Swedish Irbesartan in Left Ventricular Hypertrophy Investigation Versus Atenolol (SILVHIA)

Authors: Liljedahl, Stefan; Kahan, Thomas; Lind, Lars; Ärnlöv, Johan

Source: Echocardiography - Jnl Cardiovascular Ultrasound & Allied Techniques, Volume 26, Number 7, August 2009 , pp. 753-758(6)

Publisher: Blackwell Publishing

The Risks and Benefits of Initial Irbesartan/Hydrochlorothiazide Combination Therapy in Patients With Severe Hypertension

Authors: Lapuerta, Pablo; Franklin, Stanley

Source: The Journal of Clinical Hypertension, Volume 11, Number 5, May 2009 , pp. 277-283(7)

Publisher: Blackwell Publishing

Valsartan vs. other angiotensin II receptor blockers in the treatment of hypertension: a meta-analytical approach

Authors: Nixon, R. M.; Müller, E.; Lowy, A.; Falvey, H.

Source: International Journal of Clinical Practice, Volume 63, Number 5, May 2009 , pp. 766-775(10)

Publisher: Blackwell Publishing

Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib

Authors: Bolle, Guillaume; Patey, Natacha; Cazajous, Graldine; Robert, Caroline; Goujon, Jean-Michel; Fakhouri, Fadi; Bruneval, Patrick; Nol, Laure-Hlne; Knebelmann, Bertrand

Source: Nephrology Dialysis Transplantation, Volume 24, Number 2, February 2009 , pp. 682-685(4)

Publisher: Oxford University Press

Irbesartan and Hydrochlorothiazide Association in the Treatment of Hypertension

Authors: Derosa, Giuseppe; Ferrari, Ilaria; Cicero, Arrigo F.G.

Source: Current Vascular Pharmacology, Volume 7, Number 2, April 2009 , pp. 120-136(17)

Publisher: Bentham Science Publishers

Irbesartan a worthwhile choice for hypertension in Sweden

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 570, 2009-01-24 , pp. 5-5(1)

Publisher: Adis International

Various drugs: Drug-induced liver injury (first report with nystatin, temozolomide and xl-999): 24 case reports

Source: Reactions, Volume 1, Number 1237, 2009-01-31 , pp. 21-22(2)

Publisher: Adis International

Cardiovascular Outcomes in High-Risk Patients without Heart Failure Treated with ARBs: A Systematic Review and Meta-Analysis

Authors: Khalaf, Mohamad M. Al; Thalib, Lukman; Doi, Suhail A.R.

Source: American Journal of Cardiovascular Drugs, Volume 9, Number 1, 2009 , pp. 29-43(15)

Publisher: Adis International

A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA

Authors: Palmer, Andrew J.; Valentine, William J.; Chen, Roland; Mehin, Nazanin; Gabriel, Sylvie; Bregman, Bruno; Rodby, Roger A.

Source: Nephrology Dialysis Transplantation, Volume 23, Number 4, 29 April 2008 , pp. 1216-1223(8)

Publisher: Oxford University Press

Endothelial dysfunction and inflammation predict development of diabetic nephropathy in the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria (IRMA 2) study

Authors: Persson, Frederik; Rossing, Peter; Hovind, Peter; Stehouwer, Coen; Schalkwijk, Casper; Tarnow, Lise; Parving, Hans-Henrik

Source: Scandinavian Journal of Clinical and Laboratory Investigation, Volume 68, Number 8, 2008 , pp. 731-738(8)

Publisher: Informa Healthcare